{"SPADE_UN_11738": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11738", "Peptide Name": "CPF-4 (Derived from  CPF-C1)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "KFWKLLKKALRLWAKVL", "Sequence Length": 17, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.28371431]Gram-positive bacteria :Staphylococcuss aureus ATCC 25923 (MIC=16 μg/ml), Staphylococcuss aureus 725 (MIC=16 μg/ml), Staphylococcuss aureus 794 (MIC=8 μg/ml), Staphylococcuss aureus 936 (MIC=8 μg/ml);Gram-negative bacteria :Escherichia coli ATCC 25922 (MIC=16 μg/ml), Escherichia coli 780 (MIC=16 μg/ml), Escherichia coli 804 (MIC=16 μg/ml), Escherichia coli 850 (MIC=8 μg/ml), Pseudomonas aeruginosa ATCC 27853 (MIC=16 μg/ml), Pseudomonas aeruginosa 2760 (MIC=8 μg/ml), Pseudomonas aeruginosa 9132 (MIC=32 μg/ml), Acinetobacter baumannii ATCC 19606 (MIC=8 μg/ml), Acinetobacter baumannii 1980 (MIC=16 μg/ml), Acinetobacter baumannii 2982 (MIC=16 μg/ml), Acinetobacter baumannii 4956 (MIC=16 μg/ml)", "Hemolytic Activity": "[Ref.28371431] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml , 8% hemolysis at 128 μg/ml , 10% hemolysis at 256 μg/ml , 25% hemolysis at 512 μg/ml against human red blood cells", "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "Mixed(D-Lys1, D-Leu5, D-Lys8, D-Leu10, D-Arg11, D-Lys15)", "Structure Description": "Not found", "Formula": "C108H175N27O17", "Mass": 2141.73, "PI": 11.39, "Net Charge": 6, "Hydrophobicity": 0.22, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria", "Literature": [{"Title": "Novel Antimicrobial Peptide CPF-C1 Analogs with Superior Stabilities and Activities against Multidrug-Resistant Bacteria", "Pubmed ID": "28371431", "Reference": "Chem Biol Drug Des. 2017 Nov;90(5)690-702. doi 10.1111/cbdd.12988.", "Author": "Junqiu Xie,Qian Zhao,Sisi Li,Zhibin Yan,Jing Li,Yao Li,Lingyun Mou,Bangzhi Zhang,Wenle Yang,Xiaokang Miao,Xianxing Jiang,and Rui Wang", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28371431"}], "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CDEGHIMNOPQSTUY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 9, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11738", "Similarity": 1.0, "Sequence": "KFWKLLKKALRLWAKVL"}, {"SPADE_ID": "SPADE_UN_11739", "Similarity": 1.0, "Sequence": "KFWKLLKKALRLWAKVL"}, {"SPADE_ID": "SPADE_UN_11743", "Similarity": 0.9411764705882353, "Sequence": "KFWKLLKKALRLWKKVL"}]}}}